Wallace Richard John 4
4 · ImmunoGen, Inc. · Filed Nov 8, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Wallace Richard John
Director
Transactions
- Exercise/Conversion
Common Stock
2023-11-07$14.70/sh+10,000$147,000→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-07−10,000→ 0 totalExercise: $14.70Exp: 2023-11-12→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on 11/12/2013 and is fully vested as of the transaction date.